Foley Mark J - Insider Non-Derivative Transactions at Revance Therapeutics, Inc. (RVNC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 30, 2024, Foley Mark J's relationship to Revance Therapeutics, Inc. (RVNC) is Director,Officer (CEO), and currently has 995,935 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RVNC insiders.
Data Source: SEC.
Foley Mark J - Insider Non-Derivative Transactions of RVNC Common Stock
Foley Mark J - Insider Non-Derivative Transactions at RVNC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 1, 2024 | Acquisition -- (Common Stock) | 1000 | 2.18 | 995935 |
| Mar 16, 2024 | F -- (Common Stock) | 17228 | 5.31 | 994935 |
| Mar 16, 2024 | F -- (Common Stock) | 3305 | 5.31 | 1012163 |
| Mar 7, 2024 | P -- (Common Stock) | 30000 | 6.98 | 1015468 |
| Mar 1, 2024 | Acquisition -- (Common Stock) | 70750 | 0 | 985468 |
| Jan 1, 2024 | Acquisition -- (Common Stock) | 264 | 7.47 | 914718 |
| Aug 12, 2023 | F -- (Common Stock) | 48064 | 18.91 | 914454 |
| Aug 12, 2023 | Acquisition -- (Common Stock) | 122143 | 0 | 962518 |
| Aug 4, 2023 | Sell -- (Common Stock) | 26279 | 22.57 | 840375 |
| Jul 4, 2023 | Sell -- (Common Stock) | 26279 | 24.94 | 866654 |
| Jul 1, 2023 | Acquisition -- (Common Stock) | 1000 | 15.61 | 892933 |
| Jun 10, 2023 | Sell -- (Common Stock) | 31279 | 30.72 | 891933 |
| May 16, 2023 | Sell -- (Common Stock) | 70447 | 34.55 | 923212 |
| Mar 16, 2023 | F -- (Common Stock) | 5341 | 30.65 | 818010 |
| Mar 10, 2023 | Sell -- (Common Stock) | 70390 | 31.59 | 823351 |
| Jan 1, 2023 | Acquisition -- (Common Stock) | 605 | 12.18 | 718092 |
| Sep 23, 2022 | Acquisition -- (Common Stock) | 175649 | 0 | 893741 |
| Feb 3, 2022 | Acquisition -- (Common Stock) | 175649 | 0 | 993659 |